Purdue Pharma Enters into Exclusive Option Agreement to Acquire SpineThera and Its Non-Opioid Product Read more
Orgenesis Announces Collaboration with Hemogenyx to Develop Blood Stem Cell Replacement Product Read more
Amneal Announces Approval of Carmustine for Injection USP, 100 mg/vial – Preparing for Launch Read more
apceth Biopharma Presents Positive Data Demonstrating Efficacy of apceth-201 in Preclinial Models of Acute GvHD Read more